Loading...

PE anti-mouse/human CD45R/B220 Antibody

Pricing & Availability
Clone
RA3-6B2 (See other available formats)
Regulatory Status
RUO
Other Names
B220
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
RA3-6B2_PE_090507
C57BL/6 mouse splenocytes stained with RA3-6B2 PE
  • RA3-6B2_PE_090507
    C57BL/6 mouse splenocytes stained with RA3-6B2 PE
  • RA3-6B2_PE_CD45RB220_Antibody__04292022
    C57BL/6 mouse splenocytes were stained with CD45R/B220 (clone RA3-6B2) PE (solid line) or rat IgG2a, κ PE isotype control (dashed line).

    Data was acquired on the Moxi Flow, exported, and processed using FlowJo software.
See PE spectral data
Cat # Size Price Quantity Check Availability Save
103207 50 µg 36€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103208 200 µg 86€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45R, also known as B220, is an isoform of CD45. It is a member of the protein tyrosine phosphatase (PTP) family with a molecular weight of approximately 180-240 kD. CD45R is expressed on B cells (at all developmental stages from pro-B cells through mature B cells), activated B cells, and subsets of T and NK cells. CD45R (B220) is also expressed on a subset of abnormal T cells involved in the pathogenesis of systemic autoimmunity in MRL-Faslpr and MRL-Fasgld mice. It plays a critical role in TCR and BCR signaling. The primary ligands for CD45 are galectin-1, CD2, CD3, and CD4. CD45R is commonly used as a pan-B cell marker; however, CD19 may be more appropriate for B cell specificity.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse,Human
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Abelson murine leukemia virus-induced pre-B tumor cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.

Application References

(PubMed link indicates BioLegend citation)
  1. Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
  2. George A, et al. 1994. J. Immunol. 152:1014. (Activ)
  3. Asensi V, et al. 1989. Immunology 68:204. (Activ)
  4. Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Chang C L-T, et al. 2007. J. Immunol. 178:6984.
  9. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  10. Lang GL, et al. 2008. Blood 111:2158. PubMed
  11. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  12. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  13. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  14. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  15. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Zape J, et al. 2017. Cell Cycle. 10.1080/15384101.2017.1361569. PubMed
  2. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  3. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  4. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  5. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  6. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  7. Le TM et al. 2018. Journal of neurochemistry. 145(2):139-153 . PubMed
  8. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  9. Li J, et al. 2019. JCI Insight. 5. PubMed
  10. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  11. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  12. Zhu X et al. 2019. Cell reports. 27(4):1205-1220 . PubMed
  13. Naing A et al. 2019. Cell reports. 26(5):1242-1257 . PubMed
  14. Franks SE, et al. 2019. J Immunol. 202:3381. PubMed
  15. Rashidi M, et al. 2019. J Immunol. 203:736. PubMed
  16. Baryawno N et al. 2019. Cell. 177(7):1915-1932 . PubMed
  17. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  18. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  19. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  20. Lim J, et al. 2017. Cell. 169:523. PubMed
  21. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  22. Katsuyama T, et al. 2019. J Clin Invest. 129:5411. PubMed
  23. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  24. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  25. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  26. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  27. Chen C, et al. 2019. Cell Rep. 29:4200. PubMed
  28. Cabal-Hierro L, et al. 2020. Nat Commun. 11:1406. PubMed
  29. Oh B, et al. 2017. Plast Reconstr Surg Glob Open. 5:e1595. PubMed
  30. Uotila LM, et al. 2017. J Immunol. 199:3644. PubMed
  31. Zheng QY, et al. 2019. Front Immunol. 10:1866. PubMed
  32. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  33. Park CJ, et al. 2020. Cell Reports. 31(2):107496.. PubMed
  34. Platteel ACM, et al. 2018. Front Immunol. 1.544444444. PubMed
  35. Khatib–Massalha E, et al. 2020. Nat Commun. 2.921527778. PubMed
  36. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  37. Tsukasaki M, et al. 2020. Cell Reports. 32(10):108124. PubMed
  38. Hoyer FF, et al. 2020. Immunity. 51(5):899-914.e7.. PubMed
  39. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  40. Wang D, et al. 2005. Int Immunol. 1.527083333. PubMed
  41. Chang C, et al. 2007. J Immunol . 178:6984. PubMed
  42. Kanaya T, et al. 2008. Am J Physiol Gastrointest Liver Physiol. 295:273. PubMed
  43. Lo W, Allen D 2012. Nat Immunol. 13:880. PubMed
  44. Feng M, et al. 2012. Int Immunopharmacol. 13:135. PubMed
  45. Fu T, et al. 2011. Mol Immunol. 48:751. PubMed
  46. Faingold O, et al. 2013. J Biol Chem. 288:32852. PubMed
  47. Wu T, et al. 2014. J Leukoc Biol. 95:215. PubMed
  48. Nguyen T, et al. 2014. J Exp Med. 211:1011. PubMed
  49. Martin R, et al. 2014. PLoS One. 9:110609. PubMed
  50. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  51. White C, et al. 2015. J Immunol. 194:697. PubMed
  52. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  53. Artinger K, et al. 2015. PLoS One. 10: 0135087. PubMed
  54. Wong J, et al. 2015. Elife. 3: 07839. PubMed
  55. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  56. Adachi Y, et al. 2015. J Exp Med. 212: 1709-1723. PubMed
  57. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  58. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  59. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  60. Lu W, et al. 2016. PLoS One. 11: 0149543. PubMed
  61. Li Y, et al. 2016. Nat Commun. 7:10836. PubMed
  62. Baglaenko Y, et al. 2016. PLoS One. 11: 0150515. PubMed
  63. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  64. Onodera T, et al. 2016. J Immunol. 196: 4172 - 4184. PubMed
  65. Madsen P, et al. 2016. J Neurosci. 36: 5128 - 5143. PubMed
  66. Ma Z, et al. 2016. Clin Cancer Res. 22: 2969 - 2980. PubMed
  67. Qiu Z, et al. 2016. Sci Rep. 6:31936. PubMed
  68. Cravens P, et al. 2016. PLoS One. 11:e0165248. PubMed
  69. Ho J, et al. 2016. PLoS Biol. 14:e2000117. PubMed
  70. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  71. Nguyen T, et al. 2016. Sci Rep. 6:36906. PubMed
  72. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  73. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  74. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  75. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  76. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  77. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  78. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  79. Xu C, et al. 2020. Immunity. 53(2):417-428.e4. PubMed
  80. Murakami K, et al. 2021. Cell Reports. 34(1):108579. PubMed
  81. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  82. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  83. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  84. Gonalves S, et al. 2021. Cell Reports. 34(11):108860. PubMed
  85. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  86. Evavold CL, et al. 2021. Cell. 184(17):4495-4511.e19. PubMed
  87. Tan J, et al. 2021. iScience. 24(8):102835. PubMed
  88. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  89. Lasso P, et al. 2020. Front Immunol. 584959:11. PubMed
  90. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  91. Ha TC, et al. 2020. Hum Gene Ther. 32:458. PubMed
  92. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  93. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  94. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  95. Liang Q, et al. 2020. Front Microbiol. 11:571847. PubMed
  96. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  97. Cho K, et al. 2021. iScience. 24:103117. PubMed
  98. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  99. Bourque J, et al. 2021. Heliyon. 7:e08311. PubMed
  100. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  101. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  102. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  103. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  104. Saveljeva S, et al. 2022. Cell Metab. 34:106. PubMed
  105. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
  106. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  107. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  108. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  109. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  110. Liu B, et al. 2022. Mol Med Rep. 26:. PubMed
  111. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  112. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  113. Schreiber K, et al. 2020. Cancer Immunol Res. 8:192. PubMed
  114. Uslu M, et al. 2020. J Cell Physiol. 235:9644. PubMed
  115. Dagher T, et al. 2021. J Exp Med. 218:. PubMed
  116. Zhu L, et al. 2022. Cells. 11:. PubMed
  117. Gawish R, et al. 2022. Elife. 11:. PubMed
  118. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  119. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  120. Kang SJ, et al. 2022. Food Sci Anim Resour. 42:903. PubMed
  121. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  122. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  123. Hiyoshi H, et al. 2022. Cell Host Microbe. 30:163. PubMed
  124. Iberg CA, et al. 2022. Cell Rep. 39:110657. PubMed
  125. Yang K, et al. 2022. Sci Immunol. 7:eabn2888. PubMed
  126. Gargaro M, et al. 2022. Immunity. 55:1032. PubMed
  127. Kiani Shabestari S, et al. 2022. Cell Rep. 39:110961. PubMed
  128. Liu H, et al. 2022. Cell Rep Med. 3:100660. PubMed
  129. Albayrak E, et al. 2022. J Cell Biochem. 123:2009. PubMed
  130. Ramdas B, et al. 2022. Mol Ther. 30:2505. PubMed
  131. Lopez R, et al. 2022. Nat Biotechnol. 40:1360. PubMed
  132. Bermea KC, et al. 2022. J Vis Exp. . PubMed
  133. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  134. Huang T, et al. 2023. Cell Death Dis. 14:354. PubMed
RRID
AB_312992 (BioLegend Cat. No. 103207)
AB_312993 (BioLegend Cat. No. 103208)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

B cells, T cell subset, NK cell subset

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
B cells, NK cells, T cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID 5788 View all products for this Gene ID
UniProt
View information about CD45R on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 2    Revision Date: 04.25.2013

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account